Aldesleukin

In the US, Aldesleukin (aldesleukin systemic) is a member of the following drug classes: interleukins, miscellaneous antineoplastics and is used to treat Melanoma and Renal Cell Carcinoma.

US matches:

• Aldesleukin


• Aldesleukin Intravenous

Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

L03AC01

CAS registry number (Chemical Abstracts Service)

0110942-02-4

Chemical Formula

C690-H1115-N177-O203-S6

Molecular Weight

15600

Therapeutic Categories

Antineoplastic agent

Biological response modifier, BRM

Immunomodulator

Chemical Names

125-L-serine-2-133-interleukin 2 (human reduced) (WHO)

2-133-Interleukin 2 (human reduced), 125-L-serine- (USAN)

Des-alanyl-1, serine-125 human interleukin-2 (BAN)

Foreign Names

• Aldesleukinum (Latin)
• Aldesleukin (German)
• Aldesleukine (French)
• Aldesleukina (Spanish)

Generic Names

• Aldesleuchina (OS: DCIT)
• Aldesleukin (OS: BAN, USAN)
• Aldesleukine (OS: DCF)
• IL-2 (IS)
• Interleukin-2 human (IS: 1-des-Ala, 125 Ser)
• recombinant human interleukin-2 (IS)
• r-serHulL-2 (IS)

Brand Names

• Chiron IL-2
  Key Oncologics, South Africa



• Interleukina II
  Tecnofarma, Chile



• Proleukin
  Asofarma, Mexico; Chiron, Belgium; Chiron, Hong Kong; Chiron, Israel; Chiron, Luxembourg; Chiron, Taiwan; Chiron, United States; Novartis, Austria; Novartis, Switzerland; Novartis, Czech Republic; Novartis, Germany; Novartis, Denmark; Novartis, Spain; Novartis, France; Novartis, United Kingdom; Novartis, Hungary; Novartis, Ireland; Novartis, Italy; Novartis, Lithuania; Novartis, Netherlands; Novartis, Portugal; Raffo, Argentina; Roche, Turkey; Tecnofarma, Ecuador; Tecnofarma, Peru; Zodiac, Brazil



• Roncoleukin
  Biotech, Russian Federation

International Drug Name Search

Glossary

BAN	British Approved Name
DCF	Dénomination Commune Française
DCIT	Denominazione Comune Italiana
IS	Inofficial Synonym
OS	Official Synonym
Rec.INN	Recommended International Nonproprietary Name (World Health Organization)
USAN	United States Adopted Name
WHO	World Health Organization

Click for further information on drug naming conventions and International Nonproprietary Names.